TGFB1 and neoplasm: While hypoxia is a key barrier, solid tumors present additional obstacles including physical barriers (dense ECM), inadequate tumor trafficking, antigen heterogeneity, and an immunosuppressive milieu rich in cytokines like TGF-β (Sterner and Sterner, 2021; Martinez and Moon, 2019).